Osseointegration Implants Market Trends 2023-2028: Industry Research Report and Forecast
IMARC Group, a leading market research company, has recently releases report titled “Osseointegration Implants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global osseointegration implants market trends, size, share and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the Osseointegration Implants market?
The global osseointegration implants market size reached US$ 6,379 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 9,255 Million by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.
Request for a sample copy of this report: https://www.imarcgroup.com/osseointegration-implants-market/requestsample
Osseointegration implants are cutting-edge medical devices designed to improve the quality of life for individuals with limb loss, particularly amputations. They are constructed using biocompatible materials, such as titanium, which allows them to fuse seamlessly with the natural bone tissue of patients. They create a direct connection between the prosthesis and the bone, eliminating the need for traditional socket-based prosthetic attachments. They enhance stability, comfort, and mobility for the user, significantly improving their overall prosthetic experience. They restore a sense of natural movement and proprioception, as the connection more closely mimics the function of a real limb. They improve the mobility of patients but also their psychological well-being, as they regain a more authentic sense of self.
What is the trend in the Osseointegration Implants market?
The rising prevalence of amputations due to factors, such as diabetes, accidents, and vascular diseases, represents one of the key factors supporting the growth of the market. Besides this, the growing number of patients seeking improved prosthetic solutions like osseointegration implants is offering a favorable market outlook. In addition, osseointegration implants offer a higher quality of life for amputees.
They provide increased mobility, comfort, and improved functionality, which is appealing to patients seeking a more active and fulfilling lifestyle. Moreover, traditional socket-based prosthetics can lead to skin irritation and discomfort. Osseointegration implants eliminate these issues, leading to a reduction in complications and the need for frequent adjustments or replacements. Apart from this, ongoing research and development (R&D) activities are leading to improved implant materials, design, and surgical techniques. These advancements make osseointegration implants more accessible and safer for a wider range of patients.
Additionally, healthcare
professionals, as well as patients, are becoming more aware of the benefits of
osseointegration implants. This increasing awareness is driving the demand for
these implants as a preferred prosthetic solution. Furthermore, regulatory
bodies are increasingly recognizing the safety and efficacy of osseointegration
implants, leading to approvals and streamlined processes for implantation.
Explore Full Report with Table of Contents: https://www.imarcgroup.com/osseointegration-implants-market
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by
Product:
- Bone-Anchored Prostheses
- Dental Implants
Breakup by Material:
- Metallic
- Ceramic
- Polymeric
- Biomaterials
Breakup by
End User:
- Hospitals
- Ambulatory Surgical Centers
- Dental Clinics
Breakup by
Region:
- North America: (United States,
Canada)
- Asia Pacific: (China, Japan, India,
South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United
Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico,
Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
Bicon LLC, CONMED Corporation, Demant A/S, Dentsply Sirona Inc., Envista Holdings Corporation, Henry Schein Inc., Institut Straumann AG, Integrum AB, Medtronic plc, NuVasive Inc., Osstem Implant Co. Ltd., Smith & Nephew plc, Stryker Corporation and Zimmer Biomet.
Buy the full report with TOC and list of Figures: https://www.imarcgroup.com/checkout?id=5115&method=298
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
